There are disclosed compounds of Formula (I) that modulate or inhibit the enzymatic activity of indoleamine 2, 3-di-oxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or autoimmune diseases utilizing the compounds of the invention.